GW PHARMACEUTICALS PLC's ticker is GWPH and the CUSIP is 36197T103. A total of 277 filers reported holding GW PHARMACEUTICALS PLC in Q3 2020. The put-call ratio across all filers is 1.18 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $2,245,000 | +32.5% | 18,301 | -5.4% | 0.45% | +10.6% |
| Q1 2020 | $1,694,000 | -18.3% | 19,340 | -2.4% | 0.40% | +1.2% |
| Q4 2019 | $2,073,000 | -12.6% | 19,823 | -3.8% | 0.40% | -20.2% |
| Q3 2019 | $2,371,000 | -34.1% | 20,615 | -1.2% | 0.50% | -34.0% |
| Q2 2019 | $3,597,000 | +37.2% | 20,865 | +34.2% | 0.76% | +31.8% |
| Q1 2019 | $2,621,000 | +86.0% | 15,548 | +7.4% | 0.58% | +67.4% |
| Q4 2018 | $1,409,000 | – | 14,470 | – | 0.34% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 450,000 | $55,224,000 | 4.41% |
| Parkman Healthcare Partners LLC | 119,778 | $14,699,000 | 4.14% |
| Sio Capital Management, LLC | 94,984 | $11,656,000 | 3.40% |
| Tamarack Advisers, LP | 90,000 | $11,045,000 | 3.08% |
| Copernicus Capital Management, LLC | 22,000 | $2,700,000 | 2.96% |
| Integral Health Asset Management, LLC | 75,000 | $9,204,000 | 2.76% |
| ETF MANAGERS GROUP, LLC | 480,145 | $58,923,000 | 2.09% |
| AdvisorShares Investments LLC | 29,758 | $3,652,000 | 1.55% |
| Redwood Investments, LLC | 130,444 | $16,008,000 | 1.42% |
| CLOUGH CAPITAL PARTNERS L P | 100,746 | $12,364,000 | 1.21% |